You have 9 free searches left this month | for more free features.

City

Condition

Advanced Solid Tumors With Neuroendocrine Differentiation (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

Sponsor

Shanghai Changzheng Hospital (1)

Collaborator

Intervention

surufatinib、serplulimab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

surufatinib、serplulimab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

Not yet recruiting

Advanced Solid Tumors With Neuroendocrine Differentiation

surufatinib、serplulimab

(no location specified)

Nov 27, 2023